Search | IOVS | ARVO Journals

Access Provided By:
MIT Libraries

Forgot password?

Create an Account

View

Showing 1 – 6 of 6

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract May 2006

Relating the Visual Activities Questionnaire (VAQ) and the National Eye Institute–Visual Function Questionnaire (NEI–VFQ) in the Collaborative Initial Glaucoma Treatment Study (CIGTS)

P.A. Wren; N.K. Janz; D.C. Musch; L.M. Niziol; B.W. Gillespie; K.E. Guire

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3383.

ARVO Annual Meeting Abstract May 2006

Baseline Factors Associated With Visual Field Progression During Long–Term Treatment for Newly Diagnosed Open–Angle Glaucoma

D.C. Musch; B.W. Gillespie; L.M. Niziol; P.R. Lichter

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3450.

ARVO Annual Meeting Abstract May 2006

Baseline Factors Associated With IOP Mean and Variability During Long–Term Treatment for Newly–Diagnosed Open–Angle Glaucoma

L.M. Niziol; D.C. Musch; B.W. Gillespie; P.R. Lichter

Invest. Ophthalmol. Vis. Sci.. 2006; 47(13):3451.

ARVO Annual Meeting Abstract May 2005

Converting to the SITA–Standard Visual Field Test Strategy in the Follow–up Phase of a Clinical Trial: Agreement With the Full Threshold Visual Field Test Strategy

D.C. Musch; B.W. Gillespie; B.M. Motyka; R.P. Mills; P.R. Lichter; CIGTS Study Group

Invest. Ophthalmol. Vis. Sci.. 2005; 46(13):3730.

ARVO Annual Meeting Abstract May 2004

Does Initial Treatment Approach Matter for Newly–Diagnosed Open–Angle Glaucoma? The Differential Role of Baseline Visual Field Severity in Subsequent Loss.

D.C. Musch; B.W. Gillespie; P.R. Lichter; R. Varma; G.L. Skuta; K.E. Guire; CIGTS Study Group

Invest. Ophthalmol. Vis. Sci.. 2004; 45(13):969.

ARVO Annual Meeting Abstract May 2003

Prognostic Factors for Failure of Initial Treatment of POAG

D.C. Musch; P.R. Lichter; R.P. Mills; K.E. Guire; B.W. Gillespie; CIGTS Study Group

Invest. Ophthalmol. Vis. Sci.. 2003; 44(13):92.

Advertisement